Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality.
Guardado en:
2256-2877
2256-2915
4
2017-12-01
37
37
http://purl.org/coar/access_right/c_abf2
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
info:eu-repo/semantics/openAccess
| id |
0918aa3bff3d3bec2a3a896c2d308653 |
|---|---|
| record_format |
ojs |
| spelling |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. Peña, A. Asociación Colombiana de Hematología y Oncología (ACHO) Artículo de revista Núm. 2 , Año 2017 : Diciembre 2 4 Revista Colombiana de Hematología y Oncología Sarmiento, I. Linares, A. Solano, M. H. Cortés, M. Sossa, C. Casas, C. Text http://purl.org/coar/access_right/c_abf2 Inglés http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/publishedVersion http://purl.org/redcol/resource_type/ARTREF http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/article Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess Publication https://revista.acho.info/index.php/acho/article/view/231 Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. Background. Evidence of prophylaxis benefit in patients without inhibitors to reduce hemarthrosis and severe bleeding have not been demonstrate in patients with hemophilia A (HA) and inhibitors, however, we could assume the reduction in bleeding episodes. Several publications have shown good results of secondary prophylaxis with AICC agents to reduce safely the number of bleeding events. We report the results in hemophilia treatment centers of two cities in a developing country, with access difficulties related to the high cost of this therapy to the health system. Objective. To describe the frequency of hemarthrosis and other bleeding episodes in patients with HA and inhibitors under AICC (Feiba®) prophylaxis. application/pdf Journal article https://doi.org/10.51643/22562915.231 2256-2915 37 37 https://revista.acho.info/index.php/acho/article/download/231/204 2256-2877 2017-12-01 2017-12-01T00:00:00Z 2017-12-01T00:00:00Z 10.51643/22562915.231 |
| institution |
ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA |
| thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png |
| country_str |
Colombia |
| collection |
Revista Colombiana de Hematología y Oncología |
| title |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. |
| spellingShingle |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. Peña, A. Sarmiento, I. Linares, A. Solano, M. H. Cortés, M. Sossa, C. Casas, C. |
| title_short |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. |
| title_full |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. |
| title_fullStr |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. |
| title_full_unstemmed |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. |
| title_sort |
secondary prophylaxis with anti-inhibitor coagulant complex (aicc) : from anecdote to reality. |
| title_eng |
Secondary prophylaxis with anti-inhibitor coagulant complex (AICC) : from anecdote to reality. |
| description_eng |
Background. Evidence of prophylaxis benefit in patients without inhibitors to reduce hemarthrosis and severe bleeding have not been demonstrate in patients with hemophilia A (HA) and inhibitors, however, we could assume the reduction in bleeding episodes. Several publications have shown good results of secondary prophylaxis with AICC agents to reduce safely the number of bleeding events. We report the results in hemophilia treatment centers of two cities in a developing country, with access difficulties related to the high cost of this therapy to the health system. Objective. To describe the frequency of hemarthrosis and other bleeding episodes in patients with HA and inhibitors under AICC (Feiba®) prophylaxis.
|
| author |
Peña, A. Sarmiento, I. Linares, A. Solano, M. H. Cortés, M. Sossa, C. Casas, C. |
| author_facet |
Peña, A. Sarmiento, I. Linares, A. Solano, M. H. Cortés, M. Sossa, C. Casas, C. |
| citationvolume |
4 |
| citationissue |
2 |
| citationedition |
Núm. 2 , Año 2017 : Diciembre |
| publisher |
Asociación Colombiana de Hematología y Oncología (ACHO) |
| ispartofjournal |
Revista Colombiana de Hematología y Oncología |
| source |
https://revista.acho.info/index.php/acho/article/view/231 |
| language |
Inglés |
| format |
Article |
| rights |
http://purl.org/coar/access_right/c_abf2 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2017-12-01 |
| date_accessioned |
2017-12-01T00:00:00Z |
| date_available |
2017-12-01T00:00:00Z |
| url |
https://revista.acho.info/index.php/acho/article/view/231 |
| url_doi |
https://doi.org/10.51643/22562915.231 |
| issn |
2256-2877 |
| eissn |
2256-2915 |
| doi |
10.51643/22562915.231 |
| citationstartpage |
37 |
| citationendpage |
37 |
| url2_str_mv |
https://revista.acho.info/index.php/acho/article/download/231/204 |
| _version_ |
1797159713140375552 |